文献速递神经技术与安全PETMRCT

一体化飞行时间PET/MR成像系统中基于图谱的脑PET衰减校正的定量评估

Quantitative Evaluation of Atlas-based Attenuation Correction for Brain PET in an Integrated Time-of-Flight PET/MR Imaging System.
PubMed 文献 · Radiology · 2017-02-23

本研究纳入30例患者,在飞行时间PET/MR系统上比较四种衰减校正方法对脑PET定量的影响。基于图谱的衰减校正(ATAC)与CT衰减校正(CTAC)相比平均差异为-4.0%±3.2,使用患者自身骨可改善至-1.5%±1.5,而不含骨的ATAC差异达-9.4%±3.7。ATAC通过图谱骨补偿可达到与CTAC相似的定量精度,但患者解剖差异导致性能变异。

要点

  • 基于图谱的衰减校正(ATAC)与CTAC相比脑PET定量平均差异为-4.0%±3.2,性能随患者和脑区而异。
  • 不使用骨信息时ATACboneless差异达-9.4%±3.7,显著劣于ATAC(P<.001)。
  • 采用患者自身骨替代图谱骨后ATACpatientBone差异改善至-1.5%±1.5(P<.001)。

核心结论

  • PET/MR中的ATAC通过图谱骨补偿可达到与CTAC相似的定量精度,但患者与图谱的解剖差异导致骨衰减差异和窦腔误分类,造成ATAC性能随患者变化。

研究设计与样本

  • 经机构审查委员会批准的研究,30例招募患者签署知情同意,均行全身氟脱氧葡萄糖PET/CT后行飞行时间PET/MR成像,基于TOF PET数据用四种衰减校正方法重建PET图像,在脑内14个1mL感兴趣体积中测量平均活度浓度,用配对t检验分析。

诊断标准与关键数值

  • 以CTAC为参考,ATAC总体平均差异为-0.69 kBq/mL±0.60(-4.0%±3.2)(P<.001),范围随患者为-9.3%至0.57%、随VOI为-5.9至-2.2。
  • ATACboneless总体差异为-9.4%±3.7,显著劣于ATAC的-4.0%±3.2(P<.001)。
  • ATACpatientBone总体差异为-1.5%±1.5,优于ATAC的-4.0%±3.2(P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To assess the patient-dependent accuracy of atlas-based attenuation correction (ATAC) for brain positron emission tomography (PET) in an integrated time-of-flight (TOF) PET/magnetic resonance (MR) imaging system. Materials and Methods Thirty recruited patients provided informed consent in this institutional review board-approved study. All patients underwent whole-body fluorodeoxyglucose PET/computed tomography (CT) followed by TOF PET/MR imaging. With use of TOF PET data, PET images were reconstructed with four different attenuation correction (AC) methods: PET with patient CT-based AC (CTAC), PET with ATAC (air and bone from an atlas), PET with ATACpatientBone (air and tissue from the atlas with patient bone), and PET with ATACboneless (air and tissue from the atlas without bone). For quantitative evaluation, PET mean activity concentration values were measured in 14 1-mL volumes of interest (VOIs) distributed throughout the brain and statistical significance was tested with a paired t test. Results The mean overall difference (±standard deviation) of PET with ATAC compared with PET with CTAC was -0.69 kBq/mL ± 0.60 (-4.0% ± 3.2) (P < .001). The results were patient dependent (range, -9.3% to 0.57%) and VOI dependent (range, -5.9 to -2.2). In addition, when bone was not included for AC, the overall difference of PET with ATACboneless (-9.4% ± 3.7) was significantly worse than that of PET with ATAC (-4.0% ± 3.2) (P < .001). Finally, when patient bone was used for AC instead of atlas bone, the overall difference of PET with ATACpatientBone (-1.5% ± 1.5) improved over that of PET with ATAC (-4.0% ± 3.2) (P < .001). Conclusion ATAC in PET/MR imaging achieves similar quantification accuracy to that from CTAC by means of atlas-based bone compensation. However, patient-specific anatomic differences from the atlas causes bone attenuation differences and misclassified sinuses, which result in patient-dependent performance variation of ATAC. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Yang J, Jian Y, Jenkins N, et al. Quantitative Evaluation of Atlas-based Attenuation Correction for Brain PET in an Integrated Time-of-Flight PET/MR Imaging System. Radiology. 2017. PMID: 28234560. doi:10.1148/radiol.2017161603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。